Correlation Between Suzhou Novoprotein and Hunan Fangsheng

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Suzhou Novoprotein and Hunan Fangsheng at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Suzhou Novoprotein and Hunan Fangsheng into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Suzhou Novoprotein Scientific and Hunan Fangsheng Pharm, you can compare the effects of market volatilities on Suzhou Novoprotein and Hunan Fangsheng and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Suzhou Novoprotein with a short position of Hunan Fangsheng. Check out your portfolio center. Please also check ongoing floating volatility patterns of Suzhou Novoprotein and Hunan Fangsheng.

Diversification Opportunities for Suzhou Novoprotein and Hunan Fangsheng

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Suzhou and Hunan is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Suzhou Novoprotein Scientific and Hunan Fangsheng Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hunan Fangsheng Pharm and Suzhou Novoprotein is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Suzhou Novoprotein Scientific are associated (or correlated) with Hunan Fangsheng. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hunan Fangsheng Pharm has no effect on the direction of Suzhou Novoprotein i.e., Suzhou Novoprotein and Hunan Fangsheng go up and down completely randomly.

Pair Corralation between Suzhou Novoprotein and Hunan Fangsheng

Assuming the 90 days trading horizon Suzhou Novoprotein Scientific is expected to under-perform the Hunan Fangsheng. But the stock apears to be less risky and, when comparing its historical volatility, Suzhou Novoprotein Scientific is 1.12 times less risky than Hunan Fangsheng. The stock trades about -0.05 of its potential returns per unit of risk. The Hunan Fangsheng Pharm is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  819.00  in Hunan Fangsheng Pharm on September 5, 2024 and sell it today you would earn a total of  311.00  from holding Hunan Fangsheng Pharm or generate 37.97% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy99.79%
ValuesDaily Returns

Suzhou Novoprotein Scientific  vs.  Hunan Fangsheng Pharm

 Performance 
       Timeline  
Suzhou Novoprotein 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Suzhou Novoprotein Scientific are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Suzhou Novoprotein sustained solid returns over the last few months and may actually be approaching a breakup point.
Hunan Fangsheng Pharm 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hunan Fangsheng Pharm has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Hunan Fangsheng is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Suzhou Novoprotein and Hunan Fangsheng Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Suzhou Novoprotein and Hunan Fangsheng

The main advantage of trading using opposite Suzhou Novoprotein and Hunan Fangsheng positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Suzhou Novoprotein position performs unexpectedly, Hunan Fangsheng can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hunan Fangsheng will offset losses from the drop in Hunan Fangsheng's long position.
The idea behind Suzhou Novoprotein Scientific and Hunan Fangsheng Pharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules